IMPELLA beim kardiogenen Schock Zirkulatorische Unterstützung mit der IMPELLA Pumpe bei infarktbedingtem kardiogenem Schock: In oder out? Impella support for acute myocardial infarction complicated by cardiogenic shock: A matched-pair IABP-SHOCK II trial...
More
IMPELLA beim kardiogenen Schock Zirkulatorische Unterstützung mit der IMPELLA Pumpe bei infarktbedingtem kardiogenem Schock: In oder out? Impella support for acute myocardial infarction complicated by cardiogenic shock: A matched-pair IABP-SHOCK II trial 30-day mortality analysis. Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, et al. Circulation 2019;139:1249-1258 BACKGROUND: Percutaneous mechanical circulatory support de- RESULTS: In total, 237 patients treated with an Impella could vices are increasingly used in acute myocardial infarction complicated be matched to 237 patients from the IABP-SHOCK II trial. Baseline by cardiogenic shock (AMI-CS), despite limited evidence for their ef- parameters were similarly distributed after matching. There was no fectiveness. The aim of this study was to evaluate outcomes associ- significant difference in 30-day all-cause mortality (48.5% vs. 46.4%, ated with use of the Impella device compare
Less
